CXCL8 and neoplasm: Beyond the PPARγ/NF-κB/IL-8 axis, PEDF has been shown to bind the catalytic β-subunit of F1-ATP synthase present on the surface of various tumor cell lines inhibiting ATP production and decreasing the viability of both endothelial and tumor cell [29,30].